Determinants of adherence to glaucoma medical therapy in a long-term patient population

Journal of Glaucoma

Volumn 18, Issue 3, 2009, Pages 238-242

  Djafari, Fawzia ^a,c   Lesk, Mark R ^a,c   Harasymowycz, Paul J ^a,c   Desjardins, Daniel ^a   Lachaine, Jean ^a,b  

^a Faculty of Medicine   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Adherence; Compliance; Glaucoma; Medication; Persistency

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; MIOTIC AGENT; PROSTAGLANDIN DERIVATIVE; ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; SELF REPORT; CLASSIFICATION; DRUG EFFECT; DRUG UTILIZATION; INTRAOCULAR PRESSURE; QUESTIONNAIRE; STATISTICS;

AGED; ANTIHYPERTENSIVE AGENTS; DRUG UTILIZATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 65649126399     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181815421     Document Type: Article

References (25)

1. Weih LM, Nanjan M, McCarty CA, et al. Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology. 2001;108:1966-1972. (Pubitemid 33032762)
2. Mukesh BN, McCarty CA, Rait JL, et al. Five year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology. 2002;109:1047-1051.
3. Konstas AG, Maskaleris G, Gratsonidis S, et al. Compliance and viewpoint of glaucoma patients in Greece. Eye. 2000; 14(Pt 5):752-756. (Pubitemid 30838323)
4. Patel SC, Spaeth GL. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg. 1995;26:233-236.
5. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993;83: 711-716.
6. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye. 1998;12(Pt 2):234-236.
7. Deokule S, Sadiq S, Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol Opt. 2004;24:9-15. (Pubitemid 41711035)
8. Sleath B, Robin AL, Covert D, et al. Patient-reported behaviour and problems in using glaucoma medications. Ophthalmology. 2006;113:431-436 [Epub February 3, 2006]. (Pubitemid 43296984)
9. Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101: 515-523.
10. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol. 1986;101:524-530. (Pubitemid 16114196)
11. Boden C, Sit A, Weinreb RN. Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops. J Glaucoma. 2006;15:30-34. (Pubitemid 43068417)
12. Friedman DS, Jampel HD, Congdon NG, et al. The TRAVATAN dosing aid accurately records when drops are taken. Am J Ophthalmol. 2007;143:699-701 [Epub December 22, 2006].
13. Cronin TH, Kahook MY, Lathrop KL, et al. Accuracy and performance of a commercially available dosing aid. Br J Ophthalmol. 2007;91:497-499 [Epub August 17, 2006].
14. Robin AL, Novack GD, Covert DW, et al. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533-540 [Epub August 8, 2007].
15. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007; 48:5052-5057. (Pubitemid 351260915)
16. Fiscella RG, Green A, Patuszynski DH, et al. Medical therapy cost considerations for glaucoma. Am J Ophthalmol. 2003;136: 18-25. (Pubitemid 36794490)
17. Fiscella RG. Costs of glaucoma medications. Am J Health Syst Pharm. 1998;55:272-275.
18. Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598-606. (Pubitemid 41455298)
19. Gurwitz JH, Yeomans SL, Glynn RJ, et al. Patient noncompliance in the managed care setting: the case of medical therapy for glaucoma. Med Care. 1998;36:357-369.
20. Bloch S, Rosenthal AR, Friedman L, et al. Patient compliance in glaucoma. Br J Ophthalmol. 1977;61:531-534.
21. Taylor SA, Galbraith SM, Mills RP. Causes of noncompliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18:401-409. (Pubitemid 37420249)
22. Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12: 393-398.
23. Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eye drops. Br J Ophthalmol. 1990;74:477-480. (Pubitemid 20269092)
24. Kosoko O, Quigley HA, Vitale S, et al. Risk factors for non compliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998;105:2105-2111. (Pubitemid 30211781)
25. Covert D, Robin AL, Novack GD. Systemic medications and glaucoma patients. Ophthalmology. 2005;112:1849.